Primary prophylaxis implementation and long‐term joint outcomes in Swedish haemophilia A patients

Documenti analoghi

• Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry
  di: Nadine G. Andersson, et al.
  Pubblicazione: (2024)
• EAHAD statement on the ISTH clinical practice guideline for treatment of congenital haemophilia A and B
  di: Pratima Chowdary, et al.
  Pubblicazione: (2024)
• How much prophylaxis is enough in haemophilia?
  di: Manuel Carcao, et al.
  Pubblicazione: (2024)
• The haemophilia joint health score for the assessment of joint health in patients with haemophilia
  di: Cihan Ay, et al.
  Pubblicazione: (2024)
• Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
  di: Katarina Steen Carlsson, et al.
  Pubblicazione: (2025)